北京密水云端美容美发中心(个体工商户)-logo

北京密水云端美容美发中心(个体工商户)

20人以下

公司优势

北京密水云端美容美发中心(个体工商户),公司规模少于50人,公司类型民营公司,所属行业美容/保健。

AI智能简历诊断!

想知道你的简历存在什么问题吗?

从简历规范度、职业形象塑造、职场经历、核心能力、职场竞争力五个维度综合评估,为你的求职保驾护航!

立即诊断

20,861+ 岗位更新等你来订阅

一键订阅最新的岗位,每周送达

您可以在邮箱中随时取消订阅

广西裕达集团国际酒店有限公司成立于2009年3月10日,位于来宾市人民路西288号,属于其他一般旅馆行业。该酒店/民宿员工人数在100至499人之间,融资情况未公开。

宁波联合集团股份有限公司前身系宁波经济技术开发区联合发展有限总公司,成立于1988年5月,由宁波经济技术开发区管理委员会、中国五金矿产进出口总公司、中国机械进出口总公司三方共同投资成立,全权负责6.61平方公里开发区的规划、开发、建设、招商与管理。

1996年6月,公司正式更名“宁波联合集团股份有限公司”。1997年3月31日,公司获准向社会公开发行3000万股人民币普通股(A股),并于同年4月在上海证券交易所上市交易,股票代码为600051。

2010年4月,浙江荣盛控股集团有限公司收购宁波联合29.9%的股权,成为新控股股东。目前,宁波联合拥有6家全资子公司和控股子公司,业务涵盖基础设施、房地产、对外贸易、婚庆、旅游等多个领域。集团秉持稳健经营、持续发展的理念,已在热电、房地产和国际贸易等行业建立了领先地位,拥有一支高效的管理团队和丰富的人才资源。

公司在运营中取得了显著的经济和社会效益:自2002年至2004年,连续三年荣获“中国500强企业”称号;多年来被认定为“中国服务业500强企业”、“浙江省服务业百强企业”、“宁波市综合百强企业”及“宁波市优势总部企业”。

公司注重人才培养和发展,提供包括但不限于法定福利、节庆福利、假期福利、生活福利、恭贺福利、年度健康体检、活动类福利在内的全面福利体系。同时,公司设有优秀经营管理团队和“以人为本、和谐共享”的企业文化,为员工提供了广阔的职业发展空间。

应聘指南:
1. 公司每日收到大量简历,通常会在一周内联系合适的候选人,未能进入下一轮的应聘者将不再单独通知,敬请理解。
2. 对于未被邀请面试或面试结果不符合要求的应聘者,其资料将被存入公司人才库,作为未来可能的招聘需求之用。本公司承诺对所有应聘者的资料严格保密。

公司主要从事工程造价咨询、工程管理服务、招投标代理服务及建设工程监理、建筑工程设计等业务。

韵达快递是一家涵盖快递、物流、电子商务配送及仓储服务的全国性品牌快递企业,成立于1999年8月,总部设在中国上海,服务网络覆盖国内31个省(区、市)及港澳台地区。[1-3]
自2013年起,韵达快递陆续与日本、韩国、美国、德国、澳大利亚等国家和地区开展国际快件业务合作,为海外客户提供快递服务。

Reyoung Pharmaceutical Co., Ltd., established in 1966, is now a Singapore-listed company with a total asset value of USD 500 million and over 4000 employees. The company's headquarters is located in Yiyuan, Shandong, with branches in Songjiang District, Shanghai, and research and development centers in Yiyuan, Jinan, Shanghai, and the United States. More than 160 offices are spread across major cities in China, and its products are exported to over thirty countries including Germany, France, and South Korea.

The company's main business areas include the research and production of pharmaceuticals, covering categories such as powdered injections, raw materials, solid formulations, and traditional Chinese medicine formulations. It specializes in the development of anti-cancer drugs, new antibiotic drugs, vaccines, and treatment drugs. Reyoung is one of the largest cephalosporin raw material drug production bases in China, ranking among the top five in the country for powdered injection production. Additionally, it collaborates with over 30 universities and research institutions, including Tsinghua University and Shandong University, holding numerous patents and winning national science and technology awards. The company has undertaken five national projects and drafted standards for 42 new drug products.

Over the past four decades, Reyoung has adhered to the principle of "benefiting all quarters through Reyoung Pharmaceuticals," focusing on the development of new products and technologies, maintaining steady growth through strict quality assurance systems. The company actively participates in social welfare activities and ranks among the top 20 leading pharmaceutical companies in China. In the future, Reyoung will continue to provide high-quality products to benefit society and create high-quality employment opportunities, welcoming talented individuals to join their team.

With a footprint spanning over 343,000 square meters, Reyoung Pharm. has more than 4000 employees, approximately 21% of whom are engaged in sales and marketing. All workshops have obtained GMP certification from the Chinese SFDA, capable of producing eight categories and over 340 specifications of pharmaceutical products including tablets, capsules, granules, sterile active ingredients, small volume injections, powdered injections, freeze-dried powders for injection, and suppositories. Its sales and marketing network covers all major cities in mainland China.